The UK Pharmacogenetics & Stratified Medicine Network
The development of clinical biomarkers is crucial to providing patients with a more accurate diagnosis so they may be offered precision medicine. Precision medicine provides the patient with the most appropriate drug at the start of their treatment, at the optimum dose and combination with their other medications. The UK Pharmacogenetics and Stratified Medicine Network was set by Professor Sir Munir Pirmohamed to develop multidisciplinary research partnerships between academics, clinicians, industry partners and regulators, with patients, to promote the development of precision medicine... Read More
Clinical OMICs is the leading source for pathologists, clinicians, researchers, and scientists working to translate important findings in the broad range of “omics” technologies to deliver on the promise of molecular and precision medicine for patients. Critical information is made available through industry news, features, and thoughtful analyses emphasizing relevant knowledge and available tools.
In the era of precision medicine, new diagnostic tools will need to be finely attuned to each patient’s unique biology. As molecular technologies let us peer into the pathways of disease, 21st century diagnostics are posed to change the way our illnesses are found, treated, and even defined. At Diagnostics World News we cover the emerging technologies and questions in diagnostics. The scientific advances making precision and personalized medicine a reality are changing rapidly. It’s an exciting time for medicine and health.
GEN (Genetic Engineering & Biotechnology News) is the most widely-read publication covering tools, trends, and technologies in the biotechnology industry. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including OMICS, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
Technology Networks Group is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas.
Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.